-
Je něco špatně v tomto záznamu ?
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
MC. Nunes, C. Chauvel, SM. Raboni, FX. López-Labrador, MK. Andrew, N. Badar, V. Baillie, A. Bal, K. Baral, E. Baumeister, C. Boutros, E. Burtseva, D. Coulibaly, B. Cowling, D. Danilenko, G. Dbaibo, G. Destras, N. Dia, AC. Drăgănescu, HIG....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2007
PubMed Central
od 2007
ProQuest Central
od 2014-01-01
Open Access Digital Library
od 2007-01-01
Open Access Digital Library
od 2007-01-01
Open Access Digital Library
od 2014-01-01
Medline Complete (EBSCOhost)
od 2007-01-01
Health & Medicine (ProQuest)
od 2014-01-01
Wiley-Blackwell Open Access Titles
od 2007
ROAD: Directory of Open Access Scholarly Resources
od 2007
PubMed
40082217
DOI
10.1111/irv.70091
Knihovny.cz E-zdroje
- MeSH
- celosvětové zdraví * MeSH
- chřipka lidská * epidemiologie virologie MeSH
- COVID-19 epidemiologie MeSH
- epidemiologické monitorování MeSH
- lidé MeSH
- nemocnice * MeSH
- sekvenování celého genomu MeSH
- veřejné zdravotnictví MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance Network (GIHSN) addresses this need by collecting clinical and virological data on persons with acute respiratory illnesses across a network of hospitals worldwide. GIHSN utilizes a standardized patient enrolment and data collection protocol across its study sites. It leverages pre-existing national infrastructures and expert collaborations to facilitate comprehensive data collection. This includes demographic, clinical, epidemiological, and virologic data, and whole genome sequencing (WGS) for a subset of viruses. Sequencing data are shared in the Global Initiative on Sharing All Influenza Data (GISAID). GIHSN uses financing and governance approaches centered around public-private partnerships. Over time, GIHSN has included more than 100 hospitals across 27 countries and enrolled more than 168,000 hospitalized patients, identifying 27,562 cases of influenza and 44,629 of other respiratory viruses. GIHSN has expanded beyond influenza to include other respiratory viruses, particularly since the COVID-19 pandemic. In November 2023, GIHSN strengthened its global impact through a memorandum of understanding with the World Health Organization, aimed at enhancing collaborative efforts and data sharing for improved health responses. GIHSN exemplifies the value of integrating scientific research with public health initiatives through global collaboration and public-private partnerships governance. Future efforts should enhance the scalability of such models and ensure their sustainability through continued public and private support.
AP HP CIC Vaccinologie Cochin Pasteur Hospital Cochin Paris France
Center for Infectious Diseases Research American University of Beirut Beirut Lebanon
Center of Excellence in Respiratory Pathogens Lyon France
Dalhousie University Halifax Canada
Davila University of Medicine and Pharmacy Bucharest Romania
Department of Epidemiology Faculty of Medicine University of Novi Sad Novi Sad Serbia
Epidemiology Immunization and Infection Control Department Hospital Pequeno Principe Curitiba Brazil
FISABIO Public Health Valencia Spain
Foundation for Influenza Epidemiology Fondation de France Paris France
Global Influenza Program WHO Geneva Switzerland
HCL and CIRI Inserm U1111 CNRS UMR5308 ENS de Lyon UCBL Lyon 1 Lyon France
Icahn School of Medicine at Mount Sinai New York New York USA
Impact Healthcare Paris France
Institut National d'Hygiène Publique Abidjan Côte d'Ivoire
Institut Pasteur de Tunis Tunis Tunisia
Institut Pasteur of Dakar Dakar Senegal
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City Mexico
Kenya Medical Research Institute Nairobi Kenya
Medical University of Warsaw Warsaw Poland
Molecular Biology Microbiology Research Laboratory Universidade Federal do Paraná Curitiba Brazil
National Institute for Infectious Diseases Prof Dr Matei Bals Bucharest Romania
National Institute of Health lslamadad Pakistan
National Institute of Public Health Prague Czech Republic
Patan Academy of Health Sciences Patan Nepal
School of Public Health Fudan University Shanghai China
School of Public Health University of Hong Kong Hong Kong China
Sher i Kashmir Institute Srinagar India
Smorodintsev Research Institute of Influenza Saint Petersburg Russia
The CIRN Serious Outcomes Surveillance Network Halifax Canada
Vaccine Institute Hacettepe University Ankara Türkiye
Worldwide Influenza Centre The Francis Crick Institute London UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009598
- 003
- CZ-PrNML
- 005
- 20250429135123.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/irv.70091 $2 doi
- 035 __
- $a (PubMed)40082217
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nunes, Marta C $u Center of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL) and Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard Lyon 1 (UCBL Lyon 1), Lyon, France $1 https://orcid.org/000000033788878X
- 245 14
- $a The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration / $c MC. Nunes, C. Chauvel, SM. Raboni, FX. López-Labrador, MK. Andrew, N. Badar, V. Baillie, A. Bal, K. Baral, E. Baumeister, C. Boutros, E. Burtseva, D. Coulibaly, B. Cowling, D. Danilenko, G. Dbaibo, G. Destras, N. Dia, AC. Drăgănescu, HIG. Giamberardino, D. Gomez-Camargo, L. Josset, PA. Koul, J. Kyncl, VA. Laguna-Torres, O. Launay, LBL. Nugyen, S. McNeil, S. Medić, A. Mira-Iglesias, A. Mironenko, A. Nitsch-Osuch, A. Orrico-Sánchez, NA. Otieno, H. Regue, GM. Ruiz-Palacios, AB. Salah, M. Salman, O. Săndulescu, V. Simon, A. Sominina, E. Sordillo, MD. Tanriover, S. Unal, H. van Bakel, P. Vanhems, T. Zhang, C. Commaille-Chapus, C. Hunsinger, J. Bresee, B. Lina, JW. McCauley, JR. Ortiz, C. Viboud, W. Zhang, L. Torcel-Pagnon, C. Mahe, SS. Chaves
- 520 9_
- $a Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance Network (GIHSN) addresses this need by collecting clinical and virological data on persons with acute respiratory illnesses across a network of hospitals worldwide. GIHSN utilizes a standardized patient enrolment and data collection protocol across its study sites. It leverages pre-existing national infrastructures and expert collaborations to facilitate comprehensive data collection. This includes demographic, clinical, epidemiological, and virologic data, and whole genome sequencing (WGS) for a subset of viruses. Sequencing data are shared in the Global Initiative on Sharing All Influenza Data (GISAID). GIHSN uses financing and governance approaches centered around public-private partnerships. Over time, GIHSN has included more than 100 hospitals across 27 countries and enrolled more than 168,000 hospitalized patients, identifying 27,562 cases of influenza and 44,629 of other respiratory viruses. GIHSN has expanded beyond influenza to include other respiratory viruses, particularly since the COVID-19 pandemic. In November 2023, GIHSN strengthened its global impact through a memorandum of understanding with the World Health Organization, aimed at enhancing collaborative efforts and data sharing for improved health responses. GIHSN exemplifies the value of integrating scientific research with public health initiatives through global collaboration and public-private partnerships governance. Future efforts should enhance the scalability of such models and ensure their sustainability through continued public and private support.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chřipka lidská $x epidemiologie $x virologie $7 D007251
- 650 12
- $a celosvětové zdraví $7 D014943
- 650 12
- $a nemocnice $7 D006761
- 650 _2
- $a veřejné zdravotnictví $7 D011634
- 650 _2
- $a COVID-19 $x epidemiologie $7 D000086382
- 650 _2
- $a epidemiologické monitorování $7 D062665
- 650 _2
- $a sekvenování celého genomu $7 D000073336
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chauvel, Cecile $u Center of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL) and Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard Lyon 1 (UCBL Lyon 1), Lyon, France
- 700 1_
- $a Raboni, Sonia M $u Molecular Biology/Microbiology Research Laboratory, Universidade Federal do Paraná, Curitiba, Brazil $1 https://orcid.org/0000000179077585
- 700 1_
- $a López-Labrador, F Xavier $u FISABIO-Public Health, Valencia, Spain $1 https://orcid.org/0000000294038258
- 700 1_
- $a Andrew, Melissa K $u Dalhousie University, Halifax, Canada
- 700 1_
- $a Badar, Nazish $u National Institute of Health, lslamadad, Pakistan $1 https://orcid.org/0000000223297877
- 700 1_
- $a Baillie, Vicky $u South African Medical Research Council, Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 700 1_
- $a Bal, Antonin $u HCL and CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL Lyon 1, Lyon, France
- 700 1_
- $a Baral, Kedar $u Patan Academy of Health Sciences, Patan, Nepal
- 700 1_
- $a Baumeister, Elsa $u National Reference Laboratory for Viral Respiratory Diseases, Virology Department, INEI-ANLIS, Buenos Aires, Argentina
- 700 1_
- $a Boutros, Celina $u Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon
- 700 1_
- $a Burtseva, Elena $u Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow, Russia
- 700 1_
- $a Coulibaly, Daouda $u Institut National d'Hygiène Publique (INHP), Abidjan, Côte d'Ivoire
- 700 1_
- $a Cowling, Ben $u School of Public Health University of Hong Kong, Hong Kong, China $1 https://orcid.org/0000000262977154
- 700 1_
- $a Danilenko, Daria $u Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia
- 700 1_
- $a Dbaibo, Ghassan $u Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon $1 https://orcid.org/0000000258135878
- 700 1_
- $a Destras, Gregory $u HCL and CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL Lyon 1, Lyon, France
- 700 1_
- $a Dia, Ndongo $u Institut Pasteur of Dakar, Dakar, Senegal
- 700 1_
- $a Drăgănescu, Anca Cristina $u National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Bucharest, Romania
- 700 1_
- $a Giamberardino, Heloisa I G $u Epidemiology, Immunization and Infection Control Department, Hospital Pequeno Principe, Curitiba, Brazil
- 700 1_
- $a Gomez-Camargo, Doris $u Grupo de Investigación UNIMOL, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia
- 700 1_
- $a Josset, Laurence $u HCL and CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL Lyon 1, Lyon, France
- 700 1_
- $a Koul, Parvaiz A $u Sher-i-Kashmir Institute, Srinagar, India
- 700 1_
- $a Kyncl, Jan $u National Institute of Public Health, Prague, Czech Republic $1 https://orcid.org/0000000208042729
- 700 1_
- $a Laguna-Torres, Victor Alberto $u Clínica Internacional, Instituto de Medicina Tropical, Universidad Nacional Mayor de San Marcos, Lima, Peru
- 700 1_
- $a Launay, Odile $u Université Paris Cité, Assistance Publique - Hôpitaux de Paris (AP-HP), CIC Vaccinologie Cochin Pasteur, Hôpital Cochin, Inserm, FCRIN, I REIVAC, Paris, France
- 700 1_
- $a Nugyen, Liem Binh Luong $u AP-HP, CIC Vaccinologie Cochin Pasteur, Hospital Cochin, Paris, France
- 700 1_
- $a McNeil, Shelly $u The CIRN Serious Outcomes Surveillance (SOS) Network, Halifax, Canada
- 700 1_
- $a Medić, Snežana $u Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- 700 1_
- $a Mira-Iglesias, Ainara $u FISABIO-Public Health, Valencia, Spain $1 https://orcid.org/0000000163718229
- 700 1_
- $a Mironenko, Alla $u SI Kyiv City Center for Diseases Control and Prevention of the Ministry of Health of Ukraine, Kyiv, Ukraine $1 https://orcid.org/0000000226301827
- 700 1_
- $a Nitsch-Osuch, Aneta $u Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Orrico-Sánchez, Alejandro $u FISABIO-Public Health, Valencia, Spain
- 700 1_
- $a Otieno, Nancy A $u Kenya Medical Research Institute (KEMRI), Nairobi, Kenya $1 https://orcid.org/0000000270834735
- 700 1_
- $a Regue, Hadrien $u HCL, Lyon, France
- 700 1_
- $a Ruiz-Palacios, Guillermo M $u Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
- 700 1_
- $a Salah, Afif Ben $u Institut Pasteur de Tunis, Tunis, Tunisia
- 700 1_
- $a Salman, Muhammad $u National Institute of Health, lslamadad, Pakistan
- 700 1_
- $a Săndulescu, Oana $u Davila University of Medicine and Pharmacy, Bucharest, Romania $1 https://orcid.org/0000000225864070
- 700 1_
- $a Simon, Viviana $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 700 1_
- $a Sominina, Anna $u Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia
- 700 1_
- $a Sordillo, Emilia $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 700 1_
- $a Tanriover, Mine Durusu $u Vaccine Institute, Hacettepe University, Ankara, Türkiye
- 700 1_
- $a Unal, Serhat $u Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Türkiye
- 700 1_
- $a van Bakel, Harm $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 700 1_
- $a Vanhems, Philippe $u HCL and CIRI, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID), Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL Lyon 1, Lyon, France $1 https://orcid.org/0000000331881456
- 700 1_
- $a Zhang, Tao $u School of Public Health, Fudan University, Shanghai, China
- 700 1_
- $a Commaille-Chapus, Catherine $u Impact Healthcare, Paris, France
- 700 1_
- $a Hunsinger, Camille $u Impact Healthcare, Paris, France
- 700 1_
- $a Bresee, Joseph $u Partnership for International Vaccine Initiatives, The Task Force for Global Health, Decatur, Georgia, USA
- 700 1_
- $a Lina, Bruno $u HCL and CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL Lyon 1, Lyon, France $1 https://orcid.org/0000000289592123
- 700 1_
- $a McCauley, John W $u Worldwide Influenza Centre, The Francis Crick Institute, London, UK
- 700 1_
- $a Ortiz, Justin R $u Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA
- 700 1_
- $a Viboud, Cecile $u Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
- 700 1_
- $a Zhang, Wenqing $u Global Influenza Program, WHO, Geneva, Switzerland
- 700 1_
- $a Torcel-Pagnon, Laurence $u Foundation for Influenza Epidemiology, Fondation de France, Paris, France
- 700 1_
- $a Mahe, Cedric $u Foundation for Influenza Epidemiology, Fondation de France, Paris, France
- 700 1_
- $a Chaves, Sandra S $u Foundation for Influenza Epidemiology, Fondation de France, Paris, France
- 773 0_
- $w MED00157838 $t Influenza and other respiratory viruses $x 1750-2659 $g Roč. 19, č. 3 (2025), s. e70091
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40082217 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135118 $b ABA008
- 999 __
- $a ok $b bmc $g 2311150 $s 1246679
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 19 $c 3 $d e70091 $e - $i 1750-2659 $m Influenza and other respiratory viruses $n Influenza Other Respir Viruses $x MED00157838
- LZP __
- $a Pubmed-20250415
